Gao Shan, Gao Feng, Kong Jing-Wei, Wang Zhi-Jia, Zheng Hao-Cheng, Jiang Xin-Qi, Xu Shu-Jing, Li Shan-Lan, Lu Ming-Jun, Dai Zi-Qi, Chu Fu-Hao, Xu Bing, Lei Hai-Min
School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 102488, China.
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine Beijing 102488, China.
Zhongguo Zhong Yao Za Zhi. 2023 May;48(10):2739-2748. doi: 10.19540/j.cnki.cjcmm.20230223.301.
Ulcerative colitis(UC) is a recurrent, intractable inflammatory bowel disease. Coptidis Rhizoma and Bovis Calculus, serving as heat-clearing and toxin-removing drugs, have long been used in the treatment of UC. Berberine(BBR) and ursodeoxycholic acid(UDCA), the main active components of Coptidis Rhizoma and Bovis Calculus, respectively, were employed to obtain UDCA-BBR supramolecular nanoparticles by stimulated co-decocting process for enhancing the therapeutic effect on UC. As revealed by the characterization of supramolecular nanoparticles by field emission scanning electron microscopy(FE-SEM) and dynamic light scattering(DLS), the supramolecular nanoparticles were tetrahedral nanoparticles with an average particle size of 180 nm. The molecular structure was described by ultraviolet spectroscopy, fluorescence spectroscopy, infrared spectroscopy, high-resolution mass spectrometry, and hydrogen-nuclear magnetic resonance(H-NMR) spectroscopy. The results showed that the formation of the supramolecular nano-particle was attributed to the mutual electrostatic attraction and hydrophobic interaction between BBR and UDCA. Additionally, supramolecular nanoparticles were also characterized by sustained release and pH sensitivity. The acute UC model was induced by dextran sulfate sodium(DSS) in mice. It was found that supramolecular nanoparticles could effectively improve body mass reduction and colon shortening in mice with UC(P<0.001) and decrease disease activity index(DAI)(P<0.01). There were statistically significant differences between the supramolecular nanoparticles group and the mechanical mixture group(P<0.001, P<0.05). Enzyme-linked immunosorbent assay(ELISA) was used to detect the serum levels of tumor necrosis factor-α(TNF-α) and interleukin-6(IL-6), and the results showed that supramolecular nanoparticles could reduce serum TNF-α and IL-6 levels(P<0.001) and exhibited an obvious difference with the mechanical mixture group(P<0.01, P<0.05). Flow cytometry indicated that supramolecular nanoparticles could reduce the recruitment of neutrophils in the lamina propria of the colon(P<0.05), which was significantly different from the mechanical mixture group(P<0.05). These findings suggested that as compared with the mechanical mixture, the supramolecular nanoparticles could effectively improve the symptoms of acute UC in mice. The study provides a new research idea for the poor absorption of small molecules and the unsatisfactory therapeutic effect of traditional Chinese medicine and lays a foundation for the research on the nano-drug delivery system of traditional Chinese medicine.
溃疡性结肠炎(UC)是一种复发性、难治性炎症性肠病。黄连和牛黄作为清热排毒药物,长期用于治疗UC。分别以黄连和牛黄的主要活性成分小檗碱(BBR)和熊去氧胆酸(UDCA)为原料,通过刺激共煎工艺制备UDCA - BBR超分子纳米粒,以增强对UC的治疗效果。通过场发射扫描电子显微镜(FE - SEM)和动态光散射(DLS)对超分子纳米粒进行表征,结果表明超分子纳米粒为四面体纳米粒,平均粒径为180 nm。采用紫外光谱、荧光光谱、红外光谱、高分辨率质谱和氢核磁共振(H - NMR)光谱对分子结构进行了表征。结果表明,超分子纳米粒的形成归因于BBR与UDCA之间的相互静电吸引和疏水相互作用。此外,超分子纳米粒还具有缓释和pH敏感性。通过葡聚糖硫酸钠(DSS)诱导建立小鼠急性UC模型。结果发现,超分子纳米粒能有效改善UC小鼠的体重减轻和结肠缩短(P<0.001),并降低疾病活动指数(DAI)(P<0.01)。超分子纳米粒组与机械混合物组之间存在统计学显著差异(P<0.001,P<0.05)。采用酶联免疫吸附测定(ELISA)检测血清肿瘤坏死因子-α(TNF - α)和白细胞介素-6(IL - 6)水平,结果表明超分子纳米粒可降低血清TNF - α和IL - 6水平(P<0.001),与机械混合物组相比有明显差异(P<0.01,P<0.05)。流式细胞术表明,超分子纳米粒可减少结肠固有层中性粒细胞的募集(P<0.05),与机械混合物组有显著差异(P<0.05)。这些发现表明,与机械混合物相比,超分子纳米粒能有效改善小鼠急性UC的症状。该研究为小分子吸收差和中药治疗效果不理想提供了新的研究思路,为中药纳米药物递送系统的研究奠定了基础。